TABLE 4.
Adverse events in 77 acute pancreatitis patients.
Group | Hydromorphone (n = 39) | Pethidine (n = 38) | p-value |
---|---|---|---|
Adverse events, n (%) | 8 (20.5) | 1 (2.6) | 0.087 |
Nausea/vomiting | 5 (12.8) | 1 (2.6) | |
Urine retention | 1 (2.6) | 0 | |
Paresthesia | 1 (2.6) | 0 | |
Gastrointestinal bleeding | 1 (2.6) | 0 |